Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04311983 · ClinicalTrials.gov registry record · NA

Interventions to Help More Low-income Smokers Quit

A NA study of Tobacco Use Cessation and Smoking Behaviors, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
1,973
Enrollment target
1
Study location

NCT04311983 is a NA study of Tobacco Use Cessation and Smoking Behaviors that has completed, run by Washington University School of Medicine. The registered enrollment target is 1,973 participants, above the 830-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (138% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04311983, a NA study of Tobacco Use Cessation and Smoking Behaviors, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
1,973 participants
Enrollment target
1
Study location

Study Summary

In a Hybrid Type 2 randomized trial, 1,980 low-income smokers from nine states with high smoking prevalence will be recruited from 2-1-1 helplines to receive either current standard practice (Quitline) or expanded services (Quitline + Smoke Free Homes) to increase tobacco cessation.

Interventions

  • BEHAVIORAL Tobacco Quitline
  • BEHAVIORAL Smoke Free Home

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 1,973 participants
Start Date 2020-03-31
Est. Completion 2023-09-29
Phase NA

What the Registry Record Tells You About NCT04311983

The ClinicalTrials.gov registry entry for NCT04311983 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,973 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 830-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (138% higher). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Tobacco Use Cessation appearing as the primary indexed condition, and to 2 interventions - of which Tobacco Quitline is the first listed.

NCT04311983 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT04311983 about?

NCT04311983 is a clinical study titled "Interventions to Help More Low-income Smokers Quit". In a Hybrid Type 2 randomized trial, 1,980 low-income smokers from nine states with high smoking prevalence will be recruited from 2-1-1 helplines to receive either current standard practice (Quitline) or expanded services (Quitline + Smoke Free Homes) to increase tobacco cessation.

What is the current status of trial NCT04311983?

This trial is currently completed. It is a NA study. The enrollment target is 1,973 participants. The study started on 2020-03-31. Estimated completion is 2023-09-29.

What conditions does trial NCT04311983 study?

This clinical trial studies the following conditions: Tobacco Use Cessation, Smoking Behaviors, Health Disparity.

What interventions are being tested in trial NCT04311983?

The interventions under investigation include: Tobacco Quitline (BEHAVIORAL), Smoke Free Home (BEHAVIORAL).

Who is sponsoring clinical trial NCT04311983?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04311983 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.